1Strader DB, Wright T, Thomas DL, et al. Diagnosis, management,and treatment of hepatitis C [ J]. Hepatology, 2004, 39 (4) :1147-1171.
2Cai G, Jiang M, Zhang B, et al. Preparation and biological evaluation of a glycosylated fusion interferon directed to hepatic receptors [J]. Biol Pharm Bull, 2009, 32(3) :440-443.
3Lucas LH, Price KE, Larive CK. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements [J]. J Am Chem Soc, 2004, 126 (43): 14258-14266.
4Carter DC, Ho JX. Structure of serum albumin [ J]. Adv Protein Chem, 1994, 45:153-203.
5Zunszain PA, Ghuman J, Komatsu T, et al. Crystal structural analysis of human serum albumin complexed with hemin and fatty acid [J]. BMC Struct. Biol, 2003, 3:6.
6Huang YS, Chen Z, Yang ZY, et al. Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-alpha2b fusion protein expressed in Pichia pastoris [J]. Eur J Pharm Biopharm, 2007, 67(2) :301-308.
7Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection [ J ]. Lancet Infect Dis, 2005, 5 (9) : 558-567.
8Soriano V, Puoti M, Sulkowski M, et al. Care of patiems coinfected with HIV and hepatitis C virus :2007 updated recommendations from the HCV-HIV international panel [ J]. AIDS, 2007, 21 (9) :1073-1089.
9Patel K, Muir AJ, McHutehison JG. Diagnosis and treatment of chronic hepatitis C infection [ J ]. BMJ, 2006, 332 ( 7548 ) : 1013-1017.
10Davis GL, Albright JE, Cook SF, et al. Projecting future complications of chronic hepatitis C in the United States [ J ]. Liver Transpl, 2003, 9(4):331-338.
7Alessandro Antonelli,Silvia Martina Ferrari,Dilia Giuggioli,Andrea Di Domenicantonio,Ilaria Ruffilli,Alda Corrado,Silvia Fabiani,Santino Marchi,Clodoveo Ferri,Ele Ferrannini,Poupak Fallahi.Hepatitis C virus infection and type 1 and type 2 diabetes mellitus[J].World Journal of Diabetes,2014,5(5):586-600. 被引量：7
